Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 136,100 shares, a drop of 23.7% from the September 30th total of 178,400 shares. Approximately 1.1% of the company’s stock are short sold. Based on an average daily volume of 420,800 shares, the days-to-cover ratio is currently 0.3 days.
Wall Street Analysts Forecast Growth
Separately, LADENBURG THALM/SH SH assumed coverage on shares of Autonomix Medical in a report on Tuesday, September 3rd. They set a “buy” rating and a $1.40 price objective for the company.
Read Our Latest Stock Analysis on Autonomix Medical
Autonomix Medical Trading Down 22.1 %
Autonomix Medical (NASDAQ:AMIX – Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.14) EPS for the quarter. Equities analysts forecast that Autonomix Medical will post -0.5 earnings per share for the current year.
Autonomix Medical Company Profile
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Further Reading
- Five stocks we like better than Autonomix Medical
- Are Penny Stocks a Good Fit for Your Portfolio?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- What Does a Stock Split Mean?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Short Selling: How to Short a Stock
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.